authors
- Harb, Wael A
- Sessa, Cristiana
- Hirte, Holger
- Kaye, Stanley B
- Banerjee, Susana N
- Christinat, Alexandra
- Simantov, Ronit
- Singh, Margaret
- Sternberg, David W
- Light, Rebecca
- Poondru, Srinivasu
- Naumann, R Wendel
Final results of a phase I study evaluating the combination of linsitinib, a dual inhibitor of insulin-like growth factor-1 receptor (IGF-1R), and insulin receptor (IR) with weekly paclitaxel (PAC) in patients (Pts) with advanced solid tumors.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- May 20, 2013
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal